Charles Matine

Insider Reports History

Location
Paris, France
Signature
/s/ Charles Matine
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Matine:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bionik Laboratories Corp. Director Common Stock, par value $0.001 per share 207K $124K $0.60 09 Jun 2023 Direct

Insider Reports Filed by Charles Matine

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BNKL Bionik Laboratories Corp. 09 Jun 2023 1 $108K 4 Director 21 Jun 2023, 10:57